Baxter International (NYSE:BAX) Issues FY 2025 Earnings Guidance

Baxter International (NYSE:BAX) updated its FY 2025 earnings guidance on Thursday. The company provided EPS guidance of 2.450-2.550 for the period, compared to the consensus EPS estimate of 2.460. The company issued revenue guidance of $11.2 billion-$11.3 billion, compared to the consensus revenue estimate of $11.2 billion. Baxter International also updated its Q1 2025 guidance to 0.470-0.500 EPS.

Analysts Set New Price Targets

Several research firms recently commented on BAX. Barclays assumed coverage on Baxter International in a research report on Thursday. They set an “overweight” rating and a $39.00 target price for the company. StockNews.com downgraded Baxter International from a “buy” rating to a “hold” rating in a research report on Monday, November 11th. Citigroup cut their price objective on Baxter International from $37.00 to $35.00 and set a “neutral” rating for the company in a research report on Wednesday, December 11th. Finally, Stifel Nicolaus cut their price objective on Baxter International from $46.00 to $38.00 and set a “buy” rating for the company in a research report on Monday, November 11th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $39.40.

Baxter International Trading Up 9.0 %

Shares of NYSE BAX traded up $2.77 during midday trading on Thursday, hitting $33.59. The stock had a trading volume of 5,440,033 shares, compared to its average volume of 4,689,840. The company’s 50-day simple moving average is $30.52 and its 200 day simple moving average is $34.15. The firm has a market cap of $17.15 billion, a P/E ratio of 167.94, a price-to-earnings-growth ratio of 9.95 and a beta of 0.61. Baxter International has a fifty-two week low of $28.33 and a fifty-two week high of $44.01. The company has a debt-to-equity ratio of 1.31, a current ratio of 1.43 and a quick ratio of 1.09.

Baxter International (NYSE:BAX) last released its earnings results on Thursday, February 20th. The medical instruments supplier reported $0.58 EPS for the quarter, beating the consensus estimate of $0.52 by $0.06. Baxter International had a return on equity of 18.30% and a net margin of 0.77%. Research analysts anticipate that Baxter International will post 1.83 EPS for the current year.

Baxter International Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Friday, February 28th will be paid a dividend of $0.17 per share. The ex-dividend date is Friday, February 28th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 2.02%. Baxter International’s dividend payout ratio (DPR) is presently 340.02%.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.